These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 34404128)
1. [Value of PET/MRI in the diagnosis of malignant pleural effusion in comparison with PET/CT]. Peng WB; Sun X; Zhou M; Wei XS; Wu XZ; Ruan WW; Shi HZ; Lan XL; Zhou Q Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(30):2363-2369. PubMed ID: 34404128 [No Abstract] [Full Text] [Related]
2. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion. Yang MF; Tong ZH; Wang Z; Zhang YY; Xu LL; Wang XJ; Li W; Wu XZ; Wang W; Zhang YH; Jiang T; Shi HZ Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1457-1467. PubMed ID: 30903197 [TBL] [Abstract][Full Text] [Related]
3. The contribution of PET/CT to the differentiation of benign and malignant pleural effusion in patients with ovarian carcinoma. Budak A; Yanarateş A; Budak E Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):353-358. PubMed ID: 37172933 [TBL] [Abstract][Full Text] [Related]
4. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion]. Wei F; Wei Y; Li LF; Li GL; Wang GJ Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299 [No Abstract] [Full Text] [Related]
5. Can PET/CT be used more effectively in pleural effusion evaluation? Simsek FS; Yuksel D; Yaylali O; Aslan HS; Kılıçarslan E; Bir F; Arslan M; Can FE; Ugurlu E Jpn J Radiol; 2021 Dec; 39(12):1186-1194. PubMed ID: 34165683 [TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous whole body (18)F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging for evaluation of pediatric cancer: Preliminary experience and comparison with (18)F-fluorodeoxyglucose positron emission tomography computed tomography. Pugmire BS; Guimaraes AR; Lim R; Friedmann AM; Huang M; Ebb D; Weinstein H; Catalano OA; Mahmood U; Catana C; Gee MS World J Radiol; 2016 Mar; 8(3):322-30. PubMed ID: 27028112 [TBL] [Abstract][Full Text] [Related]
8. The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion. Sun Y; Yu H; Ma J; Lu P PLoS One; 2016; 11(8):e0161764. PubMed ID: 27560933 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion. Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951 [TBL] [Abstract][Full Text] [Related]
10. Differentiating malignant and benign pleural effusion in patients with lung cancer: an Zhang W; Liu Z; Duan X; Li Y; Shen C; Guo Y; Yang J Front Oncol; 2023; 13():1192870. PubMed ID: 37456249 [TBL] [Abstract][Full Text] [Related]
11. Added value of 40 keV virtual monoenergetic images for diagnosing malignant pleural effusion on chest CT. Kim N; Bae K; Kim HC; Jeon KN Jpn J Radiol; 2024 Aug; 42(8):862-871. PubMed ID: 38700622 [TBL] [Abstract][Full Text] [Related]
12. Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis. Zhu J; Feng M; Liang L; Zeng N; Wan C; Yang T; Shen Y; Wen F BMC Cancer; 2017 Aug; 17(1):590. PubMed ID: 28854885 [TBL] [Abstract][Full Text] [Related]
13. Lymph nodes rather than pleural metabolic activity in Jiang Y; Liu T; Xu K; Cheng Q; Lu W; Xie J; Chen M; Li Y; Du Y; Liang S; Song Y; Wu J; Lv T; Zhan P Transl Lung Cancer Res; 2024 Sep; 13(9):2236-2253. PubMed ID: 39430341 [TBL] [Abstract][Full Text] [Related]
14. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients. Kim BS; Kim IJ; Kim SJ; Pak K; Kim K Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion. Dong J; Sun G; Zhu H Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059 [TBL] [Abstract][Full Text] [Related]
16. Predictive Value of Zhang A; Meng X; Yao Y; Zhou X; Yan S; Fei W; Zhou N; Zhang Y; Kong H; Li N J Magn Reson Imaging; 2023 May; 57(5):1367-1375. PubMed ID: 36066210 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis. Tian P; Shen Y; Feng M; Zhu J; Song H; Wan C; Chen L; Wen F Postgrad Med; 2015 Jun; 127(5):529-34. PubMed ID: 25979108 [TBL] [Abstract][Full Text] [Related]
18. Derivation and validation of a 18F-FDG PET/CT scoring model to predict malignant pleural effusion. Lu P; Sun Y; Liang B; Yu L Nucl Med Commun; 2022 Feb; 43(2):177-185. PubMed ID: 34864810 [TBL] [Abstract][Full Text] [Related]
19. Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT. Zhang X; Duan H; Yu Y; Ma C; Ren Z; Lei Y; He T; Zhang M PLoS One; 2018; 13(4):e0193714. PubMed ID: 29641601 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion. Chen M; Xie S; Wan C; Zeng N; Wu Y; Qin J; Shen Y; Wen F Postgrad Med; 2017 Aug; 129(6):644-648. PubMed ID: 28506100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]